Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewTAT-cyclo-CLLFVY
Description: Selective HIF-1 dimerization inhibitor
Purity: ≥95% (HPLC)
Biological Activity for TAT-cyclo-CLLFVY
TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
Technical Data for TAT-cyclo-CLLFVY
| M. Wt | 2559.1 |
| Formula | C111H188N42O24S2 |
| Sequence |
CLLFVY CGRKKRRQRRRPPQ* (Modifications: Lactam bridge: Cys-1 to Tyr-6), Disulfide bridge: 1-1*) |
| Storage | Store at -20°C |
| Purity | ≥95% (HPLC) |
| CAS Number | 1446322-66-2 |
| PubChem ID | 72192490 |
| InChI Key | AWUUHEHYNQGEFC-XLZVTALKSA-N |
| Smiles | [H]N[C@@H](CSSC[C@@H]1N([H])C(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC1=O)C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for TAT-cyclo-CLLFVY
| Solubility | Soluble to 1 mg/ml in water |
Product Datasheets for TAT-cyclo-CLLFVY
References for TAT-cyclo-CLLFVY
References are publications that support the biological activity of the product.
Miranda et al (2013) A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J.Am.Chem.Soc. 135 10418 PMID: 23796364
If you know of a relevant reference for TAT-cyclo-CLLFVY, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: TAT-cyclo-CLLFVY, TAT-cyclo-CLLFVY supplier, HIF-1a, 1b, 1beta, 1alpha, α, β, hypoxia, inducible, factor, cancer, angiogenesis, antiangiogenic, dimerization, inhibitors, inhibits, Hypoxia, Inducible, Factors, 5582, Tocris Bioscience
Citations for TAT-cyclo-CLLFVY
Citations are publications that use Tocris products.
Currently there are no citations for TAT-cyclo-CLLFVY. Do you know of a great paper that uses TAT-cyclo-CLLFVY from Tocris? Please let us know.
Reviews for TAT-cyclo-CLLFVY
There are currently no reviews for this product. Be the first to review TAT-cyclo-CLLFVY and earn rewards!
Have you used TAT-cyclo-CLLFVY?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cancer Research Product Guide
A collection of over 750 products for cancer research, the guide includes research tools for the study of:
- Cancer Metabolism
- Epigenetics in Cancer
- Receptor Signaling
- Cell Cycle and DNA Damage Repair
- Angiogenesis
- Invasion and Metastasis
Angiogenesis in Cancer Poster
Adapted from the 2015 Cancer Product Guide, Edition 3, this poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.